Your search for bevacizumab returned 137 results

Your search for bevacizumab returned 137 results

Sort Results:

Relevant Recent
Drugs in the Pipeline

Phase 3 study of Avastin for early stage breast cancer enrollment suspended

Roche announced the suspension of enrollment by the National Cancer Institute and US Eastern Cooperative Oncology Group (ECOG) for a Phase 3 study of Avastin (bevacizumab, from Roche and Genentech) in combination with chemotherapy in women with early-stage breast cancer.
Drugs in the Pipeline

Phase 3 study of Avastin for colon cancer

Genentech announced that its Phase 3 study of Avastin (bevacizumab) plus chemotherapy following surgery in patients with early-stage colon cancer did not meet its primary endpoint of improvement in disease-free survival.
News

Anemia reported with unapproved Avastin combination

Genentech has received reports of several cases of microangiopathic hemolytic anemia (MAHA) in patients with solid tumors receiving Avastin (bevacizumab) in combination with Sutent (sunitinib malate, from Pfizer).
News

Avastin receives breast cancer approval

The FDA has granted Genentech accelerated approval for Avastin (bevacizumab), in combination with paclitaxel, for the treatment of metastatic HER2-negative breast cancer in chemotherapy-naïve patients.